A recent report published by
Infinium Global Research on cancer therapeutics and supportive care drugs
market provides in-depth analysis of segments and sub-segments in the global as
well as regional cancer therapeutics and supportive care drugs market. The
study also highlights the impact of drivers, restraints, and macro indicators
on the global and regional cancer therapeutics and supportive care drugs market
over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global cancer therapeutics
and supportive care drugs market. According to the report, the global cancer
therapeutics and supportive care drugs market is projected to grow at a CAGR of
9.4 % over the forecast period of 2019-2025.
Cancer is an abnormal growth of
cells and it is also known as malignancy. There are more than 100 types of
cancer, including breast cancer, skin cancer, lung cancer, colon cancer,
prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer
treatment may include chemotherapy, radiation, and/or surgery. New trends in
oncology drug development are reflected in the increasing use of biotechnology
in the development of anticancer drugs, including immunotherapies or monoclonal
antibodies, adoptive-cell therapies, and new vaccines.
New treatment options have become
available in the past five years, and the surge of innovation is expected to
continue due to a robust pipeline of drugs in clinical development by a large
and diverse group of pharmaceutical companies. Innovations in the development
of new drugs and therapies, a large number of new drugs entering into the
market with FDA approval, increasing prevalence of cancerous patients,
availability of new treatment options in the market and rise in base of aging the population is the key driving factors for the growth of this market. In
addition, changing lifestyle habits of populations increased patient’s
healthcare awareness and increasing demand for non-invasive therapies are
further expected to propel the market growth in the coming years. Along with
these driving factors, the market for cancer therapeutics is facing some
challenges such as time-consuming regulatory compliance and the high cost of
cancer drugs. However, the market for cancer therapeutics and supportive care drugs
is likely to rise in the future due to a large number of ongoing innovations
for the treatment of cancer.
Geographically, North America is
the leading contributor to the market and it is expected to retain its position
during the forecast period due to high awareness, the presence of a large base of
cancer patients, rise in investments, and various initiatives by government in
the healthcare sector. However, the Asia-Pacific market is expected to grow at
a faster rate during the forecast period. This is predominantly due to
increased healthcare awareness, technological advancements, significant
investments and growing awareness among the population about the treatment
options available in the market.
The report on global cancer
therapeutics and supportive care drugs market covers segments such as drug
class and distribution channel. On the basis of drug class, the sub-markets
include ESAS, bisphosphonates, opioids, G-CSFS, antiemetics, NSAIDs, and other
drug classes. On the basis of distribution channel, the sub-markets include
hospital and retail.
The report provides profiles of
the companies in the market such as Takeda
Pharmaceutical Company Ltd, Teva Pharmaceutical
Industries Ltd., AbbVie Inc., Sanofi S.A, Eli Lilly and Company, Novartis
International AG, Pfizer Inc, Johnson & Johnson, Bristol-Myers
Squibb Company,
Astellas Pharma Inc, and Other companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cancer therapeutics and supportive care drugs market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.